Published in Neurosci Lett on February 21, 2009
Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23
Genomic control for association studies. Biometrics (1999) 64.39
A fine-scale map of recombination rates and hotspots across the human genome. Science (2005) 26.82
The fine-scale structure of recombination rate variation in the human genome. Science (2004) 17.05
Assessing the impact of population stratification on genetic association studies. Nat Genet (2004) 16.28
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci (2005) 16.18
The effects of human population structure on large genetic association studies. Nat Genet (2004) 14.88
Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci (2006) 12.37
The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet (1996) 11.61
Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol (2002) 6.09
Case-control studies of association in structured or admixed populations. Theor Popul Biol (2001) 5.46
The power of genomic control. Am J Hum Genet (2000) 4.99
Population structure in admixed populations: effect of admixture dynamics on the pattern of linkage disequilibrium. Am J Hum Genet (2000) 4.74
Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev (2002) 4.23
A genomewide single-nucleotide-polymorphism panel with high ancestry information for African American admixture mapping. Am J Hum Genet (2006) 3.77
Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature (1997) 3.76
Ancestral proportions and admixture dynamics in geographically defined African Americans living in South Carolina. Am J Phys Anthropol (2001) 3.76
Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology (2007) 3.73
Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch Gen Psychiatry (2000) 3.33
Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) (2003) 3.24
The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev (2005) 3.17
Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol (2008) 2.83
Linkage analysis of a complex disease through use of admixed populations. Am J Hum Genet (2004) 2.21
Psychomotor stimulants and neuronal plasticity. Neuropharmacology (2004) 2.15
Genetic differences in alcohol sensitivity and the inheritance of alcoholism risk. Psychol Med (1999) 2.01
Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Mem (2002) 1.90
A heteromeric protein that binds to a meiotic homologous recombination hot spot: correlation of binding and hot spot activity. Genes Dev (1994) 1.82
Lower-than-expected linkage disequilibrium between tightly linked markers in humans suggests a role for gene conversion. Am J Hum Genet (2001) 1.80
Cocaine use, abuse and dependence in a population-based sample of female twins. Br J Psychiatry (1998) 1.66
Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal. Neuropsychopharmacology (1997) 1.63
Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo. Nature (2007) 1.62
A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. Proc Natl Acad Sci U S A (2006) 1.40
D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers. Biol Psychiatry (1996) 1.38
Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend (1993) 1.27
Neural mechanisms of the reinforcing action of cocaine. NIDA Res Monogr (1984) 1.27
Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology (1994) 1.23
Genetic and environmental contributions to nicotine, alcohol and cannabis dependence in male twins. Addiction (2008) 1.22
Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J Neurochem (1991) 1.20
Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience (1995) 1.19
Methodological problems in genetic association studies of longevity--the apolipoprotein E gene as an example. Int J Epidemiol (2004) 1.15
Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence. Neuropsychopharmacology (2008) 1.05
Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels. J Neurochem (1993) 1.03
A role for BDNF in cocaine reward and relapse. Nat Neurosci (2007) 0.99
Strain-selective effects of corticosterone on locomotor sensitization to cocaine and on levels of tyrosine hydroxylase and glucocorticoid receptor in the ventral tegmental area. Neuroscience (1995) 0.96
Permutation - based statistical tests for multiple hypotheses. Source Code Biol Med (2008) 0.95
Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine. J Pharmacol Exp Ther (1993) 0.95
Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3' UTR VNTR of the DAT: association with childhood ADHD in male African-Caribbean cocaine dependents? Am J Med Genet B Neuropsychiatr Genet (2007) 0.89
Homozygosity at the dopamine DRD3 receptor gene in cocaine dependence. Mol Psychiatry (1999) 0.89
Association study of dopamine D2 and D3 receptor gene polymorphisms with cocaine dependence. Psychiatr Genet (2005) 0.85
Dopamine D2 receptor gene polymorphisms and vulnerability to substance abuse in African Americans. Biol Psychiatry (1996) 0.84
Dopamine transporter gene polymorphisms are not associated with polysubstance abuse. Biol Psychiatry (1993) 0.83
Influence of cocaine on the JAK-STAT pathway in the mesolimbic dopamine system. J Neurosci (1996) 0.82
No association between D2 dopamine receptor (DRD2) alleles or haplotypes and cocaine dependence or severity of cocaine dependence in European- and African-Americans. Biol Psychiatry (1999) 0.81
No association between D3 dopamine receptor (DRD3) alleles and cocaine dependence. Addict Biol (1996) 0.79
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA (2006) 13.15
An international consensus for assessing internet gaming disorder using the new DSM-5 approach. Addiction (2014) 8.38
What's in a word? Addiction versus dependence in DSM-V. Am J Psychiatry (2006) 8.22
Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA (2005) 4.64
Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med (2006) 4.00
Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial. JAMA (2010) 3.94
A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology (2003) 3.66
A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology (2005) 3.53
Internet gaming disorder and the DSM-5. Addiction (2013) 3.46
Improving access to geriatric mental health services: a randomized trial comparing treatment engagement with integrated versus enhanced referral care for depression, anxiety, and at-risk alcohol use. Am J Psychiatry (2004) 3.28
Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial. JAMA (2013) 3.25
Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry (2002) 3.22
Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry (2006) 3.06
Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. Am J Hum Genet (2003) 3.02
DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry (2013) 2.89
The genetic determinants of smoking. Chest (2003) 2.88
Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacology (2007) 2.73
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues. Am J Psychiatry (2007) 2.60
Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study. Am J Psychiatry (2009) 2.56
The status of disulfiram: a half of a century later. J Clin Psychopharmacol (2006) 2.48
Issues for DSM-V: should obesity be included as a brain disorder? Am J Psychiatry (2007) 2.48
The effectiveness of telephone-based continuing care for alcohol and cocaine dependence: 24-month outcomes. Arch Gen Psychiatry (2005) 2.37
A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence. Am J Psychiatry (2010) 2.34
Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism. Am J Psychiatry (2014) 2.18
Prelude to passion: limbic activation by "unseen" drug and sexual cues. PLoS One (2008) 2.07
The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharmacol (2006) 2.00
Reduction in heavy drinking as a treatment outcome in alcohol dependence. J Subst Abuse Treat (2007) 1.99
Methodological challenges in constructing effective treatment sequences for chronic psychiatric disorders. Neuropsychopharmacology (2006) 1.93
Mood-incongruent psychotic features in bipolar disorder: familial aggregation and suggestive linkage to 2p11-q14 and 13q21-33. Am J Psychiatry (2007) 1.85
The effectiveness of telephone-based continuing care in the clinical management of alcohol and cocaine use disorders: 12-month outcomes. J Consult Clin Psychol (2004) 1.82
Drug treatment as HIV prevention: a research update. J Acquir Immune Defic Syndr (2010) 1.79
A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend (2004) 1.75
Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci (2011) 1.74
Symptom fluctuation in eating disorders: correlates of diagnostic crossover. Am J Psychiatry (2005) 1.69
Extended telephone-based continuing care for alcohol dependence: 24-month outcomes and subgroup analyses. Addiction (2011) 1.68
Menstrual cycle phase at quit date predicts smoking status in an NRT treatment trial: a retrospective analysis. J Womens Health (Larchmt) (2008) 1.67
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia. J Subst Abuse Treat (2006) 1.63
Deep brain stimulation compared with methadone maintenance for the treatment of heroin dependence: a threshold and cost-effectiveness analysis. Addiction (2012) 1.58
Personality characteristics of women before and after recovery from an eating disorder. Psychol Med (2004) 1.57
Comparing attentional bias to smoking cues in current smokers, former smokers, and non-smokers using a dot-probe task. Drug Alcohol Depend (2002) 1.56
Alcohol consumption among older adults in primary care. J Gen Intern Med (2007) 1.55
Temporal patterns of recovery across eating disorder subtypes. Aust N Z J Psychiatry (2008) 1.52
Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend (2003) 1.50
A randomized trial of extended telephone-based continuing care for alcohol dependence: within-treatment substance use outcomes. J Consult Clin Psychol (2010) 1.50
A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence. J Addict Med (2013) 1.47
Effects of varenicline on smoking cue–triggered neural and craving responses. Arch Gen Psychiatry (2011) 1.45
Design and sample characteristics of the PRISM-E multisite randomized trial to improve behavioral health care for the elderly. J Aging Health (2004) 1.45
Cocaine withdrawal severity and urine toxicology results from treatment entry predict outcome in medication trials for cocaine dependence. Addict Behav (2002) 1.44
Features associated with excessive exercise in women with eating disorders. Int J Eat Disord (2006) 1.40
Fine mapping of a seizure susceptibility locus on mouse Chromosome 1: nomination of Kcnj10 as a causative gene. Mamm Genome (2004) 1.39
Application of a latent class analysis to empirically define eating disorder phenotypes. Arch Gen Psychiatry (2004) 1.39
Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: a call to action. Biol Psychiatry (2004) 1.39
Retrospective study: influence of menstrual cycle on cue-induced cigarette craving. Nicotine Tob Res (2004) 1.37
Family problems among recently returned military veterans referred for a mental health evaluation. J Clin Psychiatry (2009) 1.35
Naltrexone for heroin dependence treatment in St. Petersburg, Russia. J Subst Abuse Treat (2004) 1.35
Older patients' aversion to antidepressants. A qualitative study. J Gen Intern Med (2005) 1.35
Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study. Psychol Addict Behav (2002) 1.34
Current status of co-occurring mood and substance use disorders: a new therapeutic target. Am J Psychiatry (2013) 1.33
DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacology (2008) 1.31
Relationships between features associated with vomiting in purging-type eating disorders. Int J Eat Disord (2005) 1.31
The GABA B agonist baclofen reduces cigarette consumption in a preliminary double-blind placebo-controlled smoking reduction study. Drug Alcohol Depend (2009) 1.30
Importance of subsyndromal symptoms of depression in elderly patients. Am J Geriatr Psychiatry (2005) 1.28
Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence. J Clin Psychiatry (2014) 1.26
Alcohol use disorder comorbidity in eating disorders: a multicenter study. J Clin Psychiatry (2004) 1.26
A genetic association study of the mu opioid receptor and severe opioid dependence. Psychiatr Genet (2003) 1.25
Adherence monitoring in naltrexone pharmacotherapy trials: a systematic review. J Stud Alcohol Drugs (2011) 1.25
Genome-wide association of bipolar disorder suggests an enrichment of replicable associations in regions near genes. PLoS Genet (2011) 1.23
Linkage analysis of anorexia nervosa incorporating behavioral covariates. Hum Mol Genet (2002) 1.20
Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence. J Subst Abuse Treat (2007) 1.18
Smoking in eating disorders. Eat Behav (2006) 1.18
A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms. Drug Alcohol Depend (2006) 1.17
Dopamine transporter genotype modulation of neural responses to smoking cues: confirmation in a new cohort. Addict Biol (2011) 1.16
A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention. Alcohol Clin Exp Res (2008) 1.15
Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14
Loci on chromosomes 6q and 6p interact to increase susceptibility to bipolar affective disorder in the national institute of mental health genetics initiative pedigrees. Biol Psychiatry (2004) 1.13
Pharmacogenetics and nicotine addiction treatment. Pharmacogenomics (2005) 1.13
Patterns of menstrual disturbance in eating disorders. Int J Eat Disord (2007) 1.13
PRISM-E: comparison of integrated care and enhanced specialty referral models in depression outcomes. Psychiatr Serv (2006) 1.12
Sertraline treatment of co-occurring alcohol dependence and major depression. J Clin Psychopharmacol (2006) 1.12